Sandrine Prost

Dr. Sandrine Prost

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2021 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
DDDavid Dorward
David Dorward
CRClark D. Russell
Clark D. Russell
IUIn Hwa Um
In Hwa Um
MEMustafa Elshani
Mustafa Elshani
SAStuart Armstrong
Stuart Armstrong
OCon behalf of the ICECAP consortium
on behalf of the ICECAP consortium
Rationale: In life-threatening coronavirus disease (COVID-19), corticosteroids reduce mortality, suggesting that immune responses have a causal role in death. Whether this deleterious inflammation is primarily a direct reaction to the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or an independent immunopathologic process is unknown. Objectives: To determine SARS-CoV-2 organotropism and organ-specific inflammatory responses and the relationships among viral presence, inflammation, and organ injury. Methods: Tissue was acquired from 11 detailed postmortem examinations. SARS-CoV-2 organotropism was mapped by using multiplex PCR and sequencing, with cellular resolution achieved by in situ viral S (spike) protein detection. Histologic evidence of inflammation was quantified from 37 anatomic sites, and the pulmonary immune response was characterized by using multiplex immunofluorescence. Measurements and Main Results: Multiple aberrant immune responses in fatal COVID-19 were found, principally involving the lung and reticuloendothelial system, and these were not clearly topologically associated with the virus. Inflammation and organ dysfunction did not map to the tissue and cellular distribution of SARS-CoV-2 RNA and protein between or within tissues. An arteritis was identified in the lung, which was further characterized as a monocyte/myeloid-rich vasculitis, and occurred together with an influx of macrophage/monocyte-lineage cells into the pulmonary parenchyma. In addition, stereotyped abnormal reticuloendothelial responses, including excessive reactive plasmacytosis and iron-laden macrophages, were present and dissociated from viral presence in lymphoid tissues. Conclusions: Tissue-specific immunopathology occurs in COVID-19, implicating a significant component of the immune-mediated, virus-independent immunopathologic process as a primary mechanism in severe disease. Our data highlight novel immunopathologic mechanisms and validate ongoing and future efforts to therapeutically target aberrant macrophage and plasma-cell responses as well as promote pathogen tolerance in COVID-19.

11 August 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RMRuo-Yu Ma
Ruo-Yu Ma
HZHui Zhang
Hui Zhang
XLXue-Feng Li
Xue-Feng Li
CZCheng-Bin Zhang
Cheng-Bin Zhang
CSCigdem Selli
Cigdem Selli
BQBin-Zhi Qian
Bin-Zhi Qian
Bone metastasis is the major cause of death in breast cancer. The lack of effective treatment suggests that disease mechanisms are still largely unknown. As a key component of the tumor microenvironment, macrophages promote tumor progression and metastasis. In this study, we found that macrophages are abundant in human and mouse breast cancer bone metastases. Macrophage ablation significantly inhibited bone metastasis growth. Lineage tracking experiments indicated that these macrophages largely derive from Ly6C+CCR2+ inflammatory monocytes. Ablation of the chemokine receptor, CCR2, significantly inhibited bone metastasis outgrowth and prolonged survival. Immunophenotyping identified that bone metastasis–associated macrophages express high levels of CD204 and IL4R. Furthermore, monocyte/macrophage-restricted IL4R ablation significantly inhibited bone metastasis growth, and IL4R null mutant monocytes failed to promote bone metastasis outgrowth. Together, this study identified a subset of monocyte-derived macrophages that promote breast cancer bone metastasis in an IL4R-dependent manner. This suggests that IL4R and macrophage inhibition can have potential therapeutic benefit against breast cancer bone disease.

1 December 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SPSandrine Prost
Sandrine Prost
JFJames M. Ford
James M. Ford
CTClare Taylor
Clare Taylor
JDJennifer Doig
Jennifer Doig
DHDavid J. Harrison
David J. Harrison
The mechanisms by which the hepatitis B x protein (HBx) contributes to hepatocarcinogenesis remain unclear. However, interaction with the tumor suppressor gene p53 and inhibition of p53-dependent cellular functions, including nucleotide excision repair, could be central to this process. We studied the levels of global repair (removal of cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts) and transcription-coupled repair (removal of CPDs in both strands of the dihydrofolate reductase gene) in primary wild-type and p53-null mouse hepatocytes. We show that global repair of CPDs appears to be more efficient in mouse hepatocytes than in other commonly studied rodent cells and approaches the levels of human cells and that p53 is required for global genomic DNA repair of CPDs but not for transcription-coupled repair. We then investigated the effect of HBx expression on hepatocyte nucleotide excision repair. We demonstrate that HBx expression affects DNA repair in a p53-dependent manner. Transient HBx expression reduces global DNA repair in wild-type cells to the level of p53-null hepatocytes and has no effect on the repair of a transfected damaged plasmid. Therefore, in viral hepatitis, the hepatitis B virus could inhibit the p53-dependent component of global repair leading, over time, to accumulation of genetic defects and fostering carcinogenesis.

29 August 2007 in Mammalian Genome
Verified
Journal Article
Closed access
PDF file
PLPin Lu
Pin Lu
SPSandrine Prost
Sandrine Prost
HCHelen Caldwell
Helen Caldwell
JTJonathan D. Tugwood
Jonathan D. Tugwood
GBGraham R. Betton
Graham R. Betton
DHDavid Harrison
David Harrison

1 January 2021 in OncoImmunology
Verified
Journal Article
Open access
RORichard Anthony O'Connor
Richard Anthony O'Connor
VCVishwani Chauhan
Vishwani Chauhan
LMLayla Mathieson
Layla Mathieson
HTHelen Titmarsh
Helen Titmarsh
LKLilian Koppensteiner
Lilian Koppensteiner
AAAhsan AKRAM
Ahsan AKRAM
The success of immune checkpoint therapy shows tumor-reactive T cells can eliminate cancer cells but are restrained by immunosuppression within the tumor micro-environment (TME). Cancer associated fibroblasts (CAFs) are the dominant stromal cell in the TME and co-localize with T cells in non-small cell lung cancer. We demonstrate the bidirectional nature of CAF/T cell interactions; T cells promote expression of co-inhibitory ligands, MHC molecules and CD73 on CAFs, increasing their production of IL-6 and eliciting production of IL-27. In turn CAFs upregulate co-inhibitory receptors on T cells including the ectonucleotidase CD39 promoting development of an exhausted but highly cytotoxic phenotype. Our results highlight the bidirectional interaction between T cells and CAFs in promoting components of the immunosuppressive CD39, CD73 adenosine pathway and demonstrate IL-27 production can be induced in CAF by activated T cells.

7 August 2012 in Histopathology
Verified
Journal Article
Closed access
PDF file
CBChristopher O C Bellamy
Christopher O C Bellamy
RMR Scott Maxwell
R Scott Maxwell
SPSandrine Prost
Sandrine Prost
IAIjeoma A Azodo
Ijeoma A Azodo
JPJames J Powell
James J Powell
JMJonathan R Manning
Jonathan R Manning